Dow Jones

38,589.16

-0.15%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

IDP

Idera Pharmaceutical (IDP)

Idera Pharmaceuticals

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:IDP

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
26/11/2007	12:10	Edgar (US Regulatory)	Idera Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:IDP	Idera Pharmaceuticals
21/11/2007	16:52	Edgar (US Regulatory)	Idera Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)	AMEX:IDP	Idera Pharmaceuticals
16/11/2007	15:31	Edgar (US Regulatory)	Idera Pharmaceuticals, Inc. - Securities Registration: Employee Benefit Plan (S-8)	AMEX:IDP	Idera Pharmaceuticals
13/11/2007	07:15	Edgar (US Regulatory)	Idera Pharmaceuticals, Inc. (Other) (10-Q)	AMEX:IDP	Idera Pharmaceuticals
09/11/2007	08:33	Edgar (US Regulatory)	Idera Pharmaceuticals, Inc. - Statement of Ownership (SC 13G)	AMEX:IDP	Idera Pharmaceuticals
27/09/2007	13:42	Edgar (US Regulatory)	Idera Pharmaceuticals, Inc. (Other) (4)	AMEX:IDP	Idera Pharmaceuticals
27/09/2007	13:39	Edgar (US Regulatory)	Idera Pharmaceuticals, Inc. (Other) (3)	AMEX:IDP	Idera Pharmaceuticals
27/09/2007	07:24	Edgar (US Regulatory)	Idera Pharmaceuticals, Inc. (Other) (8-K)	AMEX:IDP	Idera Pharmaceuticals
14/08/2007	07:00	Business Wire	Idera Pharmaceuticals Announces Publication of Preclinical Data on Toll-Like Receptor 7 and 8 Agonists	AMEX:IDP	Idera Pharmaceuticals
03/08/2007	07:00	Business Wire	Idera Pharmaceuticals to Present at Canaccord Adams 27th Annual Global Growth Conference	AMEX:IDP	Idera Pharmaceuticals
01/08/2007	07:30	Business Wire	Idera Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2007	AMEX:IDP	Idera Pharmaceuticals
17/07/2007	08:23	Business Wire	Idera Pharmaceuticals Announces Publication of Study of Toll-Like Receptor 9 Agonist in Combination with Avastin(R) in Preclinic	AMEX:IDP	Idera Pharmaceuticals
17/07/2007	07:00	Business Wire	Idera Pharmaceuticals Presents Preclinical Data of Toll-Like Receptor Antagonists in Rheumatoid Arthritis Models	AMEX:IDP	Idera Pharmaceuticals
21/05/2007	08:20	Business Wire	Idera Pharmaceuticals Announces Chief Financial Officer to Leave Company Effective July 31, 2007	AMEX:IDP	Idera Pharmaceuticals
15/05/2007	07:00	Business Wire	Idera Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2007	AMEX:IDP	Idera Pharmaceuticals
10/05/2007	07:00	Business Wire	Idera Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference	AMEX:IDP	Idera Pharmaceuticals
03/05/2007	07:00	Business Wire	Idera Pharmaceuticals to Present at BIO Business Forum and Participate in Toll-Like Receptor Panel at BIO 2007	AMEX:IDP	Idera Pharmaceuticals
18/04/2007	08:30	Business Wire	Idera Pharmaceuticals Announces Presentations of Preclinical Data on New Potential Oncology Applications of its TLR9 Agonists at	AMEX:IDP	Idera Pharmaceuticals
05/04/2007	07:00	Business Wire	Idera Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference	AMEX:IDP	Idera Pharmaceuticals
06/03/2007	07:00	Business Wire	Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2006 Financial Results	AMEX:IDP	Idera Pharmaceuticals
06/03/2007	06:30	Business Wire	Idera Pharmaceuticals Announces Extension of Research Collaboration on Asthma and Allergy	AMEX:IDP	Idera Pharmaceuticals
22/01/2007	08:00	PR Newswire (US)	American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007	AMEX:IDP	Idera Pharmaceuticals
11/12/2006	07:00	Business Wire	Merck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera's Toll-like Receptor Agonists in Me	AMEX:IDP	Idera Pharmaceuticals
30/11/2006	07:15	Business Wire	Idera Pharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference	AMEX:IDP	Idera Pharmaceuticals
14/11/2006	07:00	Business Wire	Idera Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2006	AMEX:IDP	Idera Pharmaceuticals
10/11/2006	09:35	Business Wire	Idera Presents Preclinical Data on Novel Class of Toll-Like Receptor Antagonists	AMEX:IDP	Idera Pharmaceuticals
01/11/2006	07:15	Business Wire	Idera Pharmaceuticals to Present at Rodman & Renshaw 8th Annual Healthcare Conference	AMEX:IDP	Idera Pharmaceuticals
24/10/2006	07:30	Business Wire	Idera to Draw Down $4 Million under Existing Equity Vehicle	AMEX:IDP	Idera Pharmaceuticals
04/10/2006	08:25	Business Wire	Idera Pharmaceuticals Announces Issuance of a US Patent for Method of Inducing an Immune Response through Administration of Immu	AMEX:IDP	Idera Pharmaceuticals
13/09/2006	07:30	Business Wire	Idera Pharmaceuticals Announces the Issuance of US Patent Claiming Compounds that Target Toll-like Receptor 9	AMEX:IDP	Idera Pharmaceuticals